$SLXP Headlines ‘Inversion’ payoff for shareholders

New Post Public Reply Private Reply Replies (0) Message Board

Aug 16, 2014 at 1:42 PM

$SLXP Headlines

‘Inversion’ payoff for shareholders is muted at tax time 11:42 a.m. Aug. 3, 2014 - Laura Saunders
Charting the approach of S&P 2,000 11:06 a.m. July 24, 2014 - Michael Ashbaugh
Another good find in specialty pharma 12:17 p.m. July 3, 2014 - The Trading Deck
S&P, Dow press uncharted territory 8:22 a.m. June 23, 2014 - Michael Ashbaugh
Playing defense in a market in transition 3:08 p.m. April 29, 2014 - The Trading Deck
Stock leaders flex muscles 2:58 p.m. Feb. 27, 2014 - The Trading Deck
The case for the bears weakens 2:55 p.m. Feb. 25, 2014 - The Trading Deck
2 leading growth stocks setting up for a move 2:29 p.m. Dec. 24, 2013 - The Trading Deck
S&P shifts to ‘good news is good news’ backdrop 1:14 p.m. Dec. 9, 2013 - Michael Ashbaugh
Nasdaq Composite rattles cage on the 4,000 mark 12:29 p.m. Nov. 25, 2013 - Michael Ashbaugh
FDA clears Salix anti-diarrheal for HIV patients 7:59 a.m. Jan. 1, 2013 - MarketWatch.com
Salix Pharmaceuticals profit rises 8:27 a.m. Aug. 9, 2012 - MarketWatch.com
Hot Stocks to watch 7:27 a.m. Aug. 9, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:15 p.m. July 30, 2012 - MarketWatch
Progenics, Salix shares hit by FDA rejection 11:29 a.m. July 30, 2012 - Val Brickates Kennedy
Progenics, Salix tumble on FDA drug rejection 10:46 a.m. July 30, 2012 - Val Brickates Kennedy
LNKD trade provides a teachable moment 12:02 a.m. March 22, 2012 - The Trading Deck
Tuesday’s biggest gaining and declining stocks 5:58 p.m. Dec. 20, 2011 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 6:17 p.m. Nov. 9, 2011 - Kate Gibson
S&P 500 nails trendline resistance 11:44 a.m. Oct. 7, 2011 - Michael Ashbaugh

Trouble For Synergy Pharmaceuticals Shorts With Pending SP-333 Trial Results 7:24 p.m. Aug. 15, 2014 - Seeking Alpha
3 Health Care Stocks Pushing The Sector Higher 1:03 p.m. Aug. 15, 2014 - TheStreet.com
Watch For Today's Momo Momentum Stock: Salix Pharmaceuticals (SLXP) 10:17 a.m. Aug. 15, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – ACT AGN GILD IRWD 9:00 a.m. Aug. 15, 2014 - InvestorPlace.com
Why Tax Inversions Won't Go Away 2:20 p.m. Aug. 13, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – INCY WST BIIB SLXP 1:45 p.m. Aug. 13, 2014 - InvestorPlace.com
Salix Pharmaceuticals, Ltd. (SLXP): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Aug. 13, 2014 - Zacks.com
Repros Therapeutics Q2 Loss a Penny Wider than Expected - Analyst Blog 10:50 a.m. Aug. 12, 2014 - Zacks.com
Salix Pharmaceuticals Beats on Q2 Earnings, Cuts Guidance - Analyst Blog 9:20 a.m. Aug. 12, 2014 - Zacks.com
Osiris Falls despite Narrower Q2 Loss and Higher Revenues - Analyst Blog 11:50 a.m. Aug. 11, 2014 - Zacks.com
Inversion Deals Are Costing The U.S. 8:58 a.m. Aug. 11, 2014 - Seeking Alpha
Leaders Actavis, Salix Trip Sell Signals 5:37 p.m. Aug. 8, 2014 - Investors Business Daily
Novo Nordisk's Earnings Rise on Solid Victoza, Levemir Sales - Analyst Blog 4:10 p.m. Aug. 8, 2014 - Zacks.com
OncoGenex Pharmaceuticals (OGXI) Soars: Stock Up 8.2% - Tale of the Tape 9:39 a.m. Aug. 8, 2014 - Zacks.com
IGI, Laboratories (IG) Jumps: Stock Adds 6.7% in Session - Tale of the Tape 8:51 a.m. Aug. 8, 2014 - Zacks.com
Salix Sinks In #PreMarket On Disappointing Outlook, Q2 Results 8:19 a.m. Aug. 8, 2014 - benzinga.com
Sterne Agee Adjusts Estimates For Salix Pharmaceuticals 8:17 a.m. Aug. 8, 2014 - benzinga.com
Salix Pharmaceuticals' (SLXP) CEO Carolyn Logan on Q2 2014 Results - Earnings Call Transcript 8:10 p.m. Aug. 7, 2014 - Seeking Alpha
Salix Q2 Misses Estimates; Novo Nordisk, Mylan Slide 5:50 p.m. Aug. 7, 2014 - Investors Business Daily
Salix Pharmaceuticals (SLXP) Q2 2014 Results - Earnings Call Webcast 4:25 p.m. Aug. 7, 2014 - Seeking Alpha

Corporate Statements, Supplemental New Drug Application, Financial Result, and Technical Update - Research Reports on Allergan, Salix, Medivation, Valeant and AstraZeneca 9:20 a.m. Aug. 13, 2014 - PR Newswire - PRF
Salix Announces Important Topline Results for Microbiome, Culture & Susceptibility, and Key Secondary Efficacy Results for TARGET 3, Rifaximin IBS-D Repeat Treatment Study 2:01 p.m. Aug. 11, 2014 - BusinessWire - BZX
FDA Assigns September 29, 2014 Prescription Drug User Fee Act Goal Date for RELISTOR® Subcutaneous Injection sNDA for the Treatment of Opioid-induced Constipation in Patients with Chronic Non-cancer Pain 7:00 a.m. Aug. 11, 2014 - BusinessWire - BZX
Salix Pharmaceuticals Reports 2Q2014 Results 4:02 p.m. Aug. 7, 2014 - BusinessWire - BZX
Lifshitz & Miller Law Firm Announces Investigation of Design Within Reach, Inc., Family Dollar Stores, Inc., GFI Group Inc., Intermountain Community Bancorp, Rockwood Holdings, Inc., and Salix Pharmaceuticals Ltd. 1:19 p.m. July 31, 2014 - PR Newswire - PRF
Salix Pharmaceuticals Announces 2Q2014 Financial Results Conference Call and Webcast 7:00 a.m. July 24, 2014 - BusinessWire - BZX
Pharma Stocks under Review -- Impax Laboratories, Sanofi, GW Pharma, AcelRx Pharma, and Salix Pharma 9:20 a.m. July 23, 2014 - PR Newswire - PRF
Salix and Pharming Announce FDA Approval of RUCONEST® for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE) 1:00 a.m. July 17, 2014 - BusinessWire - BZX
Progenics Holds Conference Call This Morning on FDA Appeal Response Regarding Relistor(R) sNDA for Patients With Chronic Non-Cancer Pain 7:05 a.m. July 14, 2014 - GlobeNewswire
FDA Office of Drug Evaluation III Approves Salix’s Request that the FDA Approve the RELISTOR® Subcutaneous Injection sNDA for the Treatment of Opioid-induced Constipation in Patients with Chronic Non-cancer Pain 7:00 a.m. July 14, 2014 - BusinessWire - BZX
Drug Application Submission, Merger Agreement, Launch of Newly Approved Drug, and Acquisition - Analyst Notes on Actavis, Salix, Mylan, Zoetis and Hospira 5:10 a.m. July 14, 2014 - PR Newswire - PRF
SALIX PHARMACEUTICALS, LTD. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Merger 11:42 a.m. July 10, 2014 - PR Newswire - PRF
SALIX SHAREHOLDER ALERT:Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Merger between Salix and Cosmo Pharmaceuticals May be Unfair to Shareholders 11:30 a.m. July 10, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of Salix Pharmaceuticals, Ltd. In Connection With The Proposed Sale Of The Company 6:10 p.m. July 9, 2014 - BusinessWire - BZX
SALIX ALERT: Proposed Sale of Salix Pharmaceuticals, Ltd. Being Investigated by Johnson & Weaver, LLP 1:32 p.m. July 9, 2014 - BusinessWire - BZX
Cadwalader Advising Salix Pharmaceuticals in its Combination with Cosmo Technologies to Form Salix Pharmaceuticals, plc 9:05 p.m. July 8, 2014 - BusinessWire - BZX
Salix Pharmaceuticals to Combine with Cosmo Technologies to Form Salix Pharmaceuticals, plc 5:00 p.m. July 8, 2014 - BusinessWire - BZX
Salix Announces Statistically Significant Primary Endpoint Result for TARGET 3 Evaluating the Efficacy and Safety of Repeat Treatment with Rifaximin 550mg in Subjects with Irritable Bowel Syndrome with Diarrhea 7:00 a.m. July 1, 2014 - BusinessWire - BZX
Patent Case Settlements, FDA Rulings, Upcoming Investor Day, Product Launching, and Closing of Offering - Analyst Notes on Teva, AstraZeneca, Salix, Mylan and GW 5:10 a.m. June 30, 2014 - PR Newswire - PRF
Salix Pharmaceuticals to Host Investor Day on July 9, 2014 7:00 a.m. June 25, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Waters Acquires MOBILion: Ion Mobility Meets AI

MOBILion Joins Waters' Fold: A New Era for Proteomics Ah, the biotech world just saw another big whirl with Waters Corporation snagging MOBILion Systems. Now, this isn't just some stroll in the market park. We're talking about weaving MOBILion's fancy high-resolution ion mobility separation tech right into Waters' already robust mass spectrometry setup. These folks are...

Montefiore Einstein Takes On Breast Cancer's Hidden Battle

Call me old-fashioned, but when cancer whispers in the shadows even after it's supposedly signed off the death certificate, you're dealing with one heck of a slippery adversary. That's where Montefiore Einstein Comprehensive Cancer Center comes in, armed with ten million greenbacks from the National Cancer Institute, primed to rattle the labyrinth of breast cancer...

JLL Snaps Up Prime Boston Warehouse for $36M

Diving Deep into JLL's Latest Acquisition If you blinked, you might have missed JLL Income Property Trust's latest power move. These folks just laid down $36 million for a prime 54,000-square-foot Class A distribution hub in Northborough, Massachusetts. This isn't just any run-of-the-mill facility; it's 100% leased to a heavy-hitting tenant for the next 14 years with neat...

Sunrate's Bold Move: New Payment Bond with Netstorming

Sunrate Joins Forces with Netstorming When two industry powerhouses shake hands, it's wise to sit up and listen. Sunrate, the global whiz in payment solutions, has linked arms with Netstorming, a tech-savvy pioneer in the travel sector. This ironclad partnership was announced at World Travel Market London 2026. Owners of travel businesses should take note: things are...

MemorialCare Expands Cutting-Edge GERD Treatment Options

Shifting the GERD Treatment Paradigm While everyone's talking about breakthrough technologies like AI and blockchain in medicine, MemorialCare seems to have quietly flipped the script on treating gastroesophageal reflux disease (GERD). They're sidestepping conventional maneuvers by embracing two procedures known as transoral incisionless fundoplication (TIF) and its...

Mill Creek's Bold Move into Denver's Cherry Creek

Taking a Stroll Down Cherry Creek The move by Mill Creek Residential into Cherry Creek North is a bold one, but they aren't exactly newcomers to this high-end neighborhood. They're planting their flag with the Modera Second Avenue, targeting Denver's upscale renters. With a Walk Score of 89, the location is a sweet spot for deep-pocketed folks who want the boutiques and...

Midterms Stir Markets; Event Contracts Fuel Q3 Gains

Midterms Mingle with Financial Markets Folks, throw those ballots into the ring, because today the midterms are kicking things off and boy, are they shaking up the game on these prediction markets. Traders and exchanges are on their toes, and the money's flowing like cold brew in July. Robinhood, Intercontinental Exchange, CME Group, and others reported noticeable ripples...

Vanessa Hering's Empathetic Model Wins 2026 Herizon Award

Recognizing a Game-Changer in Financial Wellness Vanessa Hering's name isn't just getting thrown around for no reason, folks. She's the client success officer at Beyond Finance, a heavyweight in the financial wellness arena, and she's just snagged the 2026 Herizon Award. This ain't some run-of-the-mill accolade; it acknowledges the profound changes she's spearheaded in...

Jeep Wrangler Scrambler SRT: A Bold Off-Road Rebirth

A New Legend in the Making Who would've thought we'd see the day when an SRT badge graced a Jeep Wrangler with such audacity? This ain't your typical Wrangler—they’ve slapped a bit of that CJ-8 throwback swagger, and given it the full-on SRT treatment. It's a mad machine, barreling into the future with one foot firmly planted in its legendary past. You ask any...

Ravi Bhalla Snags Top Franchise Award with $5M Milestone

From Local Fixture to National Recognition Ravi Bhalla, owner of PostalAnnex #16006 in Calabasas, CA, takes home the Crystal Award at Annex Brands' 2026 National Convention in Vegas. And let me tell you, this isn't just some shiny trophy to stuff in a display case. This is major. Shattering Sales Goals What's the big kerfuffle over? It's this: Bhalla cracked the $5...